Annual ROE
-105.37%
-52.21%-98.21%
December 31, 2023
Summary
- As of February 10, 2025, CGTX annual return on equity is -105.37%, with the most recent change of -52.21% (-98.21%) on December 31, 2023.
- During the last 3 years, CGTX annual ROE has fallen by -116.87% (-1016.26%).
- CGTX annual ROE is now -1016.26% below its all-time high of 11.50%, reached on December 31, 2020.
Performance
CGTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-150.93%
-32.82%-27.79%
September 30, 2024
Summary
- As of February 10, 2025, CGTX quarterly return on equity is -150.93%, with the most recent change of -32.82% (-27.79%) on September 30, 2024.
- Over the past year, CGTX quarterly ROE has dropped by -85.40% (-130.32%).
- CGTX quarterly ROE is now -268.34% below its all-time high of 89.66%, reached on March 31, 2022.
Performance
CGTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CGTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.2% | -130.3% |
| 3 y3 years | -1016.3% | -130.3% |
| 5 y5 years | -1371.0% | -130.3% |
CGTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -361.1% | at low | -268.3% | at low |
| 5 y | 5-year | -1016.3% | at low | -268.3% | at low |
| alltime | all time | -1016.3% | at low | -268.3% | at low |
Cognition Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -150.93%(+27.8%) |
| Jun 2024 | - | -118.11%(+19.7%) |
| Mar 2024 | - | -98.65%(+18.2%) |
| Dec 2023 | -105.37%(+98.2%) | -83.48%(+27.4%) |
| Sep 2023 | - | -65.53%(+8.0%) |
| Jun 2023 | - | -60.65%(+1.7%) |
| Mar 2023 | - | -59.61%(+19.9%) |
| Dec 2022 | -53.16% | -49.70%(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -51.42%(-63.3%) |
| Jun 2022 | - | -140.15%(-256.3%) |
| Mar 2022 | - | 89.66%(+257.8%) |
| Dec 2021 | -22.85%(-298.7%) | 25.06%(+207.5%) |
| Sep 2021 | - | 8.15%(+21.1%) |
| Jun 2021 | - | 6.73%(-10.4%) |
| Mar 2021 | - | 7.51%(-34.7%) |
| Dec 2020 | 11.50%(+38.7%) | 11.50% |
| Dec 2019 | 8.29% | - |
FAQ
- What is Cognition Therapeutics annual return on equity?
- What is the all time high annual ROE for Cognition Therapeutics?
- What is Cognition Therapeutics annual ROE year-on-year change?
- What is Cognition Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly ROE year-on-year change?
What is Cognition Therapeutics annual return on equity?
The current annual ROE of CGTX is -105.37%
What is the all time high annual ROE for Cognition Therapeutics?
Cognition Therapeutics all-time high annual return on equity is 11.50%
What is Cognition Therapeutics annual ROE year-on-year change?
Over the past year, CGTX annual return on equity has changed by -52.21% (-98.21%)
What is Cognition Therapeutics quarterly return on equity?
The current quarterly ROE of CGTX is -150.93%
What is the all time high quarterly ROE for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly return on equity is 89.66%
What is Cognition Therapeutics quarterly ROE year-on-year change?
Over the past year, CGTX quarterly return on equity has changed by -85.40% (-130.32%)